Peramivir Hydrate

帕拉米韦

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NamePeramivir Hydrate
Drug Alias Nameperamivirum帕那米韦帕拉米伟帕拉米韦水合物培拉米尔 +[16] 
ClassificationSmall molecules
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsHeadacheFatigue +[10] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryJapan
Original Approved Date2010/01/13
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[33] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDae Han New Pharmco LtdBiocryst Pharmaceuticals IncGuangzhou Nanxin Pharma Co Ltd +[4] 
Inactive CompaniesChinese University Of Hong Kong (Cuhk)National Institute Of Allergy And Infectious Diseases (Niaid)Tianjin Taipu Medicine Technology Development Co Ltd +[4] 
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsHeadacheFatigueFever +[7] 

Other Information

ATC CodeJ05AH03
Related LinksWikipediaDrugBankKEGG